| Net profit of Indo US Bio-Tech declined 46.47% to Rs 1.97 crore in the quarter ended March 2026 as against Rs 3.68 crore during the previous quarter ended March 2025. Sales declined 22.05% to Rs 26.02 crore in the quarter ended March 2026 as against Rs 33.38 crore during the previous quarter ended March 2025.
For the full year,net profit declined 19.36% to Rs 13.12 crore in the year ended March 2026 as against Rs 16.27 crore during the previous year ended March 2025. Sales rose 6.36% to Rs 110.44 crore in the year ended March 2026 as against Rs 103.84 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | | Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. |
| Sales | 26.02 | 33.38 | -22 | 110.44 | 103.84 | 6 |
| OPM % | 12.41 | 13.69 | - | 15.40 | 18.24 | - |
| PBDT | 2.65 | 4.43 | -40 | 14.82 | 17.63 | -16 |
| PBT | 2.38 | 3.87 | -39 | 13.92 | 16.53 | -16 |
| NP | 1.97 | 3.68 | -46 | 13.12 | 16.27 | -19 |
|